Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.
暂无分享，去创建一个
J. Berlin | A. Bardia | D. Juric | J. Diamond | J. O’Shaughnessy | W. Messersmith | P. Maliakal | S. Isakoff | I. Mayer | D. Goldenberg | V. Abramson | S. Tolaney | R. Sharkey | S. Govindan | L. Vahdat | W. Wegener | A. Starodub | A. Ocean | K. Kalinsky | R. Moroose | N. Shah | M. Guarino